Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis-Reference-Cited by-同舟云学术

Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

Published:2021-01 Issue:1 Volume:84 Page:60-69
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Langley Richard G.,Poulin Yves,Srivastava Bhaskar,Lafferty Kimberly Parnell,Fakharzadeh Steven,Langholff Wayne,Augustin Matthias

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Dermatology

Reference37 articles.

1. Update on psoriasis immunopathogenesis and targeted immunotherapy;Mahil;Semin Immunopathol,2016

2. Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation;Swindell;PLoS One,2013

3. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study;Mehta;Arch Dermatol,2011

4. The importance of early treatment in psoriasis and management of disease progression;Kerdel;J Drugs Dermatol,2018

5. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives;Boehncke;Curr Rheumatol Rep,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early intervention and cumulative life course impairment in psoriasis: a review;Clinical and Experimental Dermatology;2024-07-24

2. Psoriasis as a systemic disease;Deutsches Ärzteblatt international;2024-07-12

3. Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study;Journal of the American Academy of Dermatology;2024-07

4. A case-control study: epigenetic age acceleration in psoriasis;Archives of Dermatological Research;2024-06-07

5. Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2024-03-03